Xenomics Files U.S. Patent on Tuberculosis Diagnostic Test

Xenomics, a developer of medical DNA technologies, announced that it has filed a U.S. patent for technology enabling the improved detection of tuberculosis based on its Transrenal DNA technology which uses simple, easily obtained urine samples.

()a href="http://today.reuters.com/stocks/QuoteCompanyNewsArticle.aspx?view=PR&symbol=XNOM&storyID=247851%2B01-Jun-2005%2BBW" target="_blank">Reuters